A simple, non-invasive treatment focused on the ears could one day provide relief for people with ulcerative colitis, a UM ...

Upadacitinib may offer superior disease management than tofacitinib for patients with ulcerative colitis. Learn more.

Teva Pharmaceuticals and Sanofi announced positive results in a Phase 2b trial of their drug for ulcerative colitis and Crohn ...

WE USE MEDICATIONS CALLED MESALAMINE OR FIVE ... SO NO ONE REALLY UNDERSTANDS WHY YOU DEVELOP ULCERATIVE COLITIS AND CROHN’S DISEASE, BUT IT’S CLEARLY GENETICS ARE IMPORTANT.

The search for effective therapies in ulcerative colitis, a chronic inflammatory condition affecting the colon and rectum ...

They are a common form of treatment used in ulcerative colitis. In ulcerative colitis, your immune system mistakenly attacks healthy cells in the lining of the colon and rectum. As a result ...

Opens in a new tab or window ORLANDO -- Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar 1-year outcomes ...

U.S.-traded shares of Teva Pharmaceuticals (TEVA) and Sanofi (SNY) took off Tuesday after the two drugmakers reported positive results from a study of their treatment for ulcerative colitis (UC ...

The symptoms of UC are unpredictable. On a given day it can cause an urge to use the bathroom repeatedly, or blood in your stool, and then the next you may not experience any symptoms at all. Once ...

More than half (62.7%) of respondents reported facing financial barriers to obtaining their IBD medication.

Researchers have uncovered potentially diagnostic gut microbiome signatures and metabolic pathways associated specifically ...